Payment Disclosure

PHYSICIAN RESEARCH COLLABORATION

$294
paid by Amgen »
Listed practitioner: MELVIN ALBERT JR. CHURCHILL
Location: LINCOLN, Neb.
Payment for: Research
Payment for: Research
Reported: Jan. to Dec. 2013 Research
Search for PHYSICIAN RESEARCH COLLABORATION in Prescriber Checkup, our database of prescribing patterns within Medicare's drug program.

Notable drugs produced by Amgen include:

Neulasta (Makes white blood cells, prevents infections during cancer treatments)
Neupogen (Makes white blood cells, prevents infections during cancer treatments)
Enbrel (Rheumatoid arthritis, psioratic arthritis, ankylosing spondylitis, plaque psoriasis in adults, juvenile idiopathic arthritis)
Arenesp (Anemia via kidney failure or chemotherapy)
Epogen (Anemia)
Sensipar (Lowers calcium in blood)
Vectibix (Metastatic cancer of the colon or rectum)
Nplate (Chronic immune thrombocytopenia)
Xgeva (Osteoporosis, bone cancer, bone related problems in cancer patients)
Prolia (Osteoporosis, bone cancer, bone related problems in cancer patients)
Kyprolis (Multiple myeloma)

See the company's complete list »

Important notes

Research payments are distinct from speaking and consulting. The figure listed does not reflect the actual compensation received by the physician listed as the principal investigator.

Payments for clinical studies may include costs associated with patient care, supplies, as well as the time spent by health care professionals treating patients and managing the study.

The reports include both the name of the health provider who performed the service and, when reported, the entity paid. They may be different.

Source: PharmaShine

I think this is my doctor — what should I do?

If your provider is listed, it’s because a drug company reported paying him or her for promotional activities, meals, travel, educational items, consulting or research. Such payments are legal, but research has shown that drug-company marketing can influence what a doctor prescribes. How you can use this data »